Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-087899
Filing Date
2025-06-18
Accepted
2025-06-18 16:15:10
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3824
  Complete submission text file 0000950170-25-087899.txt   5299
Mailing Address C/O INCYTE CORPORATION, EXPERIMENTAL STN ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 WILMINGTON DE 19880
Business Address
Huber Reid M (Reporting) CIK: 0001607052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42121 | Film No.: 251057135

Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)